Why Viemed Healthcare Inc’s (VMD) Stock Is Down 6.02%

By AAII Staff
November 06, 2023
Featured Tickers:
VMD

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Viemed Healthcare Inc before investing.

In this article, we go over a few key elements for understanding Viemed Healthcare Inc’s stock price such as:

  • Viemed Healthcare Inc’s current stock price and volume
  • Why Viemed Healthcare Inc’s stock price changed recently
  • Upgrades and downgrades for VMD from analysts
  • VMD’s stock price momentum as measured by its relative strength

About Viemed Healthcare Inc (VMD)

Before we jump into Viemed Healthcare Inc’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Viemed Healthcare, Inc. (Viemed), through its subsidiaries, is a provider of in-home durable medical equipment (DME) and post-acute respiratory healthcare services in the United States. Viemed is focused on providing in-home treatment with clinical practitioners providing therapy and counseling to patients in their homes using technology. Viemed?s products and services include Home Medical Equipment and In-home sleep testing. Home Medical Equipment provides respiratory and other home medical equipment, including home ventilation, bi-level positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) devices, percussion vests, and other medical equipment. It provides home medical equipment through a range of service programs, including respiratory disease management, Neuromuscular care, Oxygen therapy and Sleep apnea. In-home sleep testing provides in home sleep apnea testing services, which is an alternative to the traditional sleep lab testing environment.

Want to learn more about Viemed Healthcare Inc’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Viemed Healthcare Inc.

Learn More About A+ Investor

Viemed Healthcare Inc’s Stock Price as of Market Close

As of November 06, 2023, 4:00 PM, CST, Viemed Healthcare Inc’s stock price was $7.03.

Viemed Healthcare Inc is down 6.02% from its previous closing price of $7.48.

During the last market session, Viemed Healthcare Inc’s stock traded between $6.89 and $7.71. Currently, there are 38.44 million shares of Viemed Healthcare Inc stock available for purchase.

Viemed Healthcare Inc’s price-earnings (P/E) ratio is currently at 29.7, which is high compared to the Healthcare Facilities & Services industry median of 23.9. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

Viemed Healthcare Inc Stock Price History

Viemed Healthcare Inc’s (VMD) price is currently up 11.41% so far this month.

During the month of November, Viemed Healthcare Inc’s stock price has reached a high of $7.71 and a low of $5.90.

Over the last year, Viemed Healthcare Inc has hit prices as high as $12.01 and as low as $5.90. Year to date, Viemed Healthcare Inc’s stock is up 34.67%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Viemed Healthcare Inc Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of November 03, 2023, there was 1 analyst who downgraded Viemed Healthcare Inc’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Viemed Healthcare Inc’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Viemed Healthcare Inc’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Viemed Healthcare Inc’s current valuation based on AAII’s Value Grade is a C, which means it is considered to be Average.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Viemed Healthcare Inc (VMD) by visiting AAII Stock Evaluator.

Relative Price Strength of Viemed Healthcare Inc

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of November 03, 2023, Viemed Healthcare Inc has a weighted four-quarter relative price strength of -1.42%, which translates to a Momentum Score of 63 and is considered to be Strong.

Want to learn more about how Viemed Healthcare Inc is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Viemed Healthcare Inc Stock Price: Bottom Line

As of November 6, 2023, Viemed Healthcare Inc’s stock price is $7.03, which is down 6.02% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Viemed Healthcare Inc stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.

Learn More About A+ Investor

Find New Stock Opportunities With Included With AAII Platinum
Zweig Screen: 11.3% Compared to S&P 500
at only 6.9%

Gain Since Inception. Data as of 12/31/2024.




Try AAII Platinum and get full access to
769.3% Stock Superstars Portfolio Total Return Since Inception
Compare to:
710.3% iShare DOW Jones
U.S. Index ETF (IYY)

SSR Group 3 O'Shaughnessy portfolio has a 411.2% gain since inception performance compared to IYY at only 119.1%% Performance as of 11/29/24.

Get your free copy of our special report analyzing the tech stocks most likely to outperform the market.

Download the FREE Report Here:

BECOME A MEMBER FOR ONLY $2

Get access to powerful investment discovery tools and a wealth of investment education to help you achieve your financial goals.